Hayfin Provides $27.8MM Term Loan to Sinclair Pharma
Hayfin Capital Management provided a €23 million ($27.805 million) debt facility consisting of a five-year term loan to Sinclair Pharma, an international aesthetics company.
April 30, 2018
Hayfin Capital Management | Howard Rowe | Sinclair Pharma
Amanda Koprowski